[{"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0673-2023", "product_description": "Cardioplegia Solution, Modified St Thomas Formula, HIGH POTASSIUM, 122 mEq K, packaged in 1000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0209-1.", "product_quantity": "329 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893789, Exp 04/28/2023; 37-894318, Exp 04/29/2023; 37-895648, Exp 05/05/2023; 37-897301, Exp 05/12/2023; 37-898815, Exp 05/18/2023"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204022"], "brand_name": ["ROPINIROLE"], "generic_name": ["ROPINIROLE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-232", "16729-233", "16729-234", "16729-235", "16729-236", "16729-237", "16729-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROPINIROLE HYDROCHLORIDE"], "rxcui": ["283858", "312845", "312846", "312847", "312849", "314208", "562704"], "spl_id": ["23980eef-2eb5-2b74-e063-6394a90a68ac"], "spl_set_id": ["4a2a5b63-5b14-6975-e054-00144ff8d46c"], "package_ndc": ["16729-232-01", "16729-233-01", "16729-234-01", "16729-235-01", "16729-236-01", "16729-237-01", "16729-238-01"], "is_original_packager": [true], "unii": ["D7ZD41RZI9"], "upc": ["316729235013"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0428-2023", "product_description": "rOPINIRole Tablets USP 2 mg*, 100-count bottle, Rx Only,  Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA. NDC 16729-235-01, UPC 3 16729 23501 3", "product_quantity": "25,344 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2106370, P2106369, Exp. Date 9/30/2023, P2201254, Exp. Date 2/29/2024", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0315-2023", "product_description": "PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3.375 GM IN NS 50ML, (e) 36 GM IN NS 533 ML,  antibiotic, Rx only, use with a Curlin or home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "78 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 25-31, 2022"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0851-2023", "product_description": "Tobramycin Ophthalmic Solution, USP 0.3%, 5mL bottles, Rx only, Manufactured by: Akorn , Inc, Lake Forest, IL 60045. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1066-2023", "product_description": "PHENYLephrine in 0.9% sodium chloride, 1000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6009-1", "product_quantity": "81,073 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270449, 17-270450, 17-270453, 17-270462, 17-270465, 17-270466, 17-270494, 17-270495, 17-270502, 17-270541, Exp. 7/16/2023; 17-270582, 17-270585, 17-270587, 17-270592, 17-270593, 17-270598, 17-270610, 17-270611, 17-270612, Exp. 7/17/2023; 17-270900, 17-270902, 17-270906, 17-270907, 17-270908, 17-270909, 17-270953, 17-270955, 17-270991, 17-270993, Exp. 7/23/2023; 17-271047, 17-271048, 17-271050, 17-271053, Exp. 7/24/2023; 17-271344, 17-271349, 17-271355, 17-271356, 17-271405, 17-271406, Exp. 7/31/2023; 17-271478, 17-271479, 17-271480, 17-271484, 17-271495, 17-271500, Exp. 7/31/2023; 17-271744, 17-271763, Exp. 8/3/2023; 17-271838, 17-271851, Exp. 8/6/2023; 17-271871, 17-271873, 17-271886, 17-271887, 17-271892, 17-271899, 17-271900, 17-271901, 17-271902, Exp. 8/7/2023; 17-272067, 17-272068, 17-272069, 17-272095, Exp. 8/9/2023; 17-272102, 17-272141, 17-272142, Exp. 8/10/2023; 17-272205, 17-272235, 17-272237, 17-272240, 17-272242, Exp. 8/13/2023; 17-272307, 17-272308, Exp. 8/14/2023; 17-272391, 17-272392, 17-272395, Exp. 8/15/2023; 17-272472, Exp. 8/16/2023; 17-272538, Exp. 8/17/2023; 17-272558, 17-272560, 17-272564, 17-272593, 17-272594, 17-272618, 17-272619, 17-272651, 17-272653, 17-272680, Exp. 8/20/2023; 17-272697, 17-272727, 17-272729, Exp. 8/21/2023; 17-272775, 17-272791, 17-272820, 17-272821, Exp. 8/22/2023; 17-272904, 17-272918, 17-272919, 17-272920, 17-272921, 17-272929, Exp. 8/23/2023; 17-272930, 17-272974, 17-272993, 17-272994, 17-272995, 17-272996, Exp. 8/24/2023; 17-272999, 17-273003, 17-273004, 17-273005, 17-273006, 17-273007, Exp. 8/27/2023; 17-273080, Exp. 8/28/2023; 17-273151, 17-273175, 17-273176, 17-273185, Exp. 8/29/2023; 17-273252, 17-273265, 17-273266, Exp. 8/30/2023; 17-273345, 17-273351, 17-273352, 17-273355, 17-273356, 17-273358, 17-273359, 17-273360, Exp. 8/31/2023; 17-273402, 17-273408, 17-273416, 17-273440, 17-273441, 17-273447, Exp. 9/3/2023; 17-273487, 17-273488, 17-273489, 17-273490, 17-273491, 17-273499, 17-273510, 17-273516, Exp. 9/4/2023; 17-273587, 17-273589, 17-273596, 17-273597, 17-273610, 17-273614, 17-273666, Exp. 9/5/2023; 17-273617, 17-273665, 17-273703, 17-273704, 17-273713, 17-273714, 17-273720, 17-273721, 17-273730, 17-273737, 17-273739, Exp. 9/6/2023; 17-273773, Exp. 9/7/2023; 17-273802, 17-273803, 17-273808, 17-273809, 17-273815, 17-273848, 17-273869, 17-273874, 17-273880, 17-273881, 17-273893, Exp. 9/10/2023; 17-273903, 17-273958, 17-273960, 17-273961, 17-273964, 17-273965, Exp. 9/11/2023."}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203701"], "brand_name": ["ACYCLOVIR SODIUM"], "generic_name": ["ACYCLOVIR SODIUM"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-154", "55150-155"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ACYCLOVIR SODIUM"], "rxcui": ["1734932", "1734934"], "spl_id": ["410e306b-e8b9-4ff5-b703-a3005eec272f"], "spl_set_id": ["ae921e4e-b8ae-4a45-acc1-32e5e719812b"], "package_ndc": ["55150-154-10", "55150-155-20"], "is_original_packager": [true], "upc": ["0355150155200", "0355150154104"], "unii": ["927L42J563"]}, "product_type": "Drugs", "event_id": "91406", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0095-2023", "product_description": "Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only,  Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20", "product_quantity": "45,250 vials", "reason_for_recall": "Presence of Particulate Matter: Customer complaint of dark particles found inside the vial", "recall_initiation_date": "20221228", "center_classification_date": "20230103", "report_date": "20230111", "code_info": "Lot # AC22004, Expiry: 08/2023"}, {"status": "Ongoing", "city": "Tesuque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92952", "recalling_firm": "Dr. Berne's Whole Health Products", "address_1": "174 Tesuque Village Rd Unit 458", "address_2": "N/A", "postal_code": "87574-2030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and UK, Canada, Italy, India, Australia, Germany, Switzerland, Singapore, Netherlands, Ireland, South Korea, Belgium, Norway, Saudi- Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, Barbados.", "recall_number": "D-0036-2024", "product_description": "Dr. Berne's MSM DROPS 5% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM, 87574, hello@drsamberne.com, UPC 00854582001111.", "product_quantity": "3833 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230826", "center_classification_date": "20231004", "report_date": "20231011", "code_info": "Lot: 6485, Exp: 11/23: 6562, Exp: 03/24; 6624, Exp: 06/24; 6669, Exp: 08/24; 6688, Exp: 09/24; 6727, EXP: 11/24; 6771, Exp: 02/25; 6830, Exp: 03/25; 6887, Exp: 07/25."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1126-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 20mg/250ml (80 mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-7025-1.", "product_quantity": "297 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260037, Exp 10/3/2023.              ;"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0102-2023", "product_description": "Mitomycin Injection Solution, 4mg/ml, packaged in a 10 mL Multiple-Dose vial, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "2 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 12062022@7, Exp 1/20/2023; 12072022@32, Exp 1/22/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1125-2023", "product_description": "PHENYLephrine, added to 0.9% sodium chloride, 10mg/250ml (40mcg/mL), IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043,  NDC: 72196-6058-1.", "product_quantity": "586 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-260034, 36-260033, Exp 10/3/2023.              ;"}, {"status": "Terminated", "city": "Trujillo Alto", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91325", "recalling_firm": "Frenda Corporation", "address_1": "Calle A Lote 7 Parque Ind Las Cuevas", "address_2": "N/A", "postal_code": "00976", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Puerto Rico", "recall_number": "D-0259-2023", "product_description": "Global Care Antibacterial Hand Sanitizer Alcohol Etilico 70% Original, 1 Gallon (128 FL OZ) 3785.41 mL, Dist. by Target Price, Inc. Catano, PR, UPC 8 70373 01326 2", "product_quantity": "124 bottles", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20221215", "center_classification_date": "20230130", "termination_date": "20240910", "report_date": "20230208", "code_info": "Lot: C013121"}, {"status": "Terminated", "city": "Oklahoma City", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92081", "recalling_firm": "PD-Rx Pharmaceuticals, Inc.", "address_1": "727 N Ann Arbor Ave", "address_2": "", "postal_code": "73127-5822", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-0558-2023", "product_description": "Simvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottle (NDC 43063-0727-30) b) 90 count-bottle (NDC 43063-0727-90)", "product_quantity": "37 bottles", "reason_for_recall": "CGMP deviations.", "recall_initiation_date": "20230406", "center_classification_date": "20230501", "termination_date": "20240430", "report_date": "20230510", "code_info": "Lots: a) K22E32 Exp. 10/31/23; b) H22C33 Exp. 09/30/23; H22C81, J22C83, K22E36 Exp. 10/31/23", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0339-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0117-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220556, Exp. 11/2023; 221058, Exp. 04/2024."}, {"status": "Terminated", "city": "Berlin", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91786", "recalling_firm": "Breckenridge Pharmaceutical, Inc", "address_1": "15 Massirio Dr Ste 201", "address_2": "N/A", "postal_code": "06037-2352", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-0459-2023", "product_description": "Alprazolam Tablets, USP, 0.5mg, CIV, packaged in: a) 100-count bottle (NDC 51991-0705-01), b) 500-count bottle (NDC 51991-0705-05) and c) 1,000-count bottle (NDC  51991-0705-10), Rx only, Manufactured by Centaur Pharmaceuticals PVT. LTD., Hinjewadi, Pune, INDIA, Distributed by: Breckenridge Pharmaceuticals, Inc., Berlin, CT 06037.", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Potential risk of Cross Contamination", "recall_initiation_date": "20230302", "center_classification_date": "20230310", "termination_date": "20240321", "report_date": "20230322", "code_info": "Lot #  a) 5210673, exp. date 3/31/2023; 5210901, exp. date 5/31/2023; 5211461, exp. date 9/30/2024; 5220291, exp. date 2/28/2025; 5220559, exp. date 5/31/2025; b) 5210650, exp. date 3/31/2023,  5210651, exp. date 3/31/2023  5210652, exp. date 3/31/2023  5210653, exp. date 3/31/2023  5210674, exp. date 3/31/2023  5210732, exp. date 3/31/2023  5210733, exp. date 4/30/2023  5210753, exp. date 4/30/2023  5210902, exp. date 5/31/2023  5210903, exp. date 5/31/2023  5210904, exp. date 5/31/2023  5211231, exp. date 7/31/2023  5211281, exp. date 7/31/2024  5211282, exp. date 7/31/2024  5211283, exp. date 7/31/2024  5211284, exp. date 7/31/2024  5211336, exp. date 7/31/2024  5211337, exp. date 8/31/2024  5211338, exp. date 8/31/2024  5211462, exp. date 9/30/2024  5211463, exp. date 9/30/2024  5211464, exp. date 9/30/2024  5211465, exp. date 9/30/2024  5211516, exp. date 9/30/2024  5211644, exp. date 10/31/2024  5211645, exp. date 10/31/2024  5211690, exp. date 10/31/2024   c) 5210675, exp. date 3/31/2023 5210777, exp. date 4/30/2023  5210778, exp. date 4/30/2023  5210996, exp. date 5/31/2023  5211077, exp. date 6/30/2023  5211078, exp. date 6/30/2023  5211079, exp. date 6/30/2023  5211080, exp. date 6/30/2023  5211364, exp. date 8/31/2024  5211365, exp. date 8/31/2024  5211367, exp. date 8/31/2024  5211366, exp. date 8/31/2024  5211575, exp. date 10/31/2024  5211576, exp. date 10/31/2024  5211694, exp. date 11/30/2024  5220066, exp. date 12/31/2024"}, {"status": "Ongoing", "city": "Lincoln", "state": "RI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92268", "recalling_firm": "Denison Pharmaceuticals, LLC", "address_1": "1 Powder Hill Rd", "address_2": "N/A", "postal_code": "02865-4407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide.", "recall_number": "D-0775-2023", "product_description": "Safe tussin PM, NIGHT TIME Cough Relief, (Dextromethorphan HBr, USP 7.5mg, Doxylamine Succinate 3.125mg), 4.0 FL OZ (118mL) bottle, Kramer Laboratories , Inc. Bridgewater, NJ 08807.", "product_quantity": "13,968 bottles", "reason_for_recall": "CGMP Deviations: Use of non-food grade lubricant in mixing vessel.", "recall_initiation_date": "20230503", "center_classification_date": "20230531", "report_date": "20230607", "code_info": "Lot 8639, Exp: 8/2023"}, {"status": "Ongoing", "city": "Park City", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91708", "recalling_firm": "Nutraceutical Corporation", "address_1": "1777 Sun Peak Dr", "address_2": "", "postal_code": "84098-6502", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0437-2023", "product_description": "NaturalCare bioAllers, Allergy Nasal Spray, Homeopathic, All Region Formula, 0.8 fl oz( 24mL), Mfd. Nutraceutical Corp., NaturalCare Park City, UT, 84098 USA,  UPC 3 71400 70801 9", "product_quantity": "13,974", "reason_for_recall": "CGMP Deviations: Raw material recalled by repackager, due to discoloration.", "recall_initiation_date": "20230223", "center_classification_date": "20230307", "report_date": "20230315", "code_info": "Lot: 221263, Exp: 10/24; 222047, 222048 Exp: 02/25; 222099, 222100, Exp: 03/25", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0314-2023", "product_description": "PENICILLIN (a) 40MU IN D5W 400ML(CONTINUOUS), (b) 40U IN D5W 400ML(CONTINUOUS), (c) 48MU IN D5W 480ML, antibiotic, Rx Only, use with a Curlin pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "8 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 25-31, 2022"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0808-2023", "product_description": "Guaifenesin Oral Solution, 300 mg/ 15 mL, Sugar Free/Alcohol Free, Rx Only, For Institutional Use Only,  Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0116-2023", "product_description": "TriMix Injection (PGE1/Papaverine HCl/Phentolamine Mesylate) 100mcg/30mg/3mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11212022@7, Exp 1/5/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0605-2023", "product_description": "Cefepime for Injection, USP 2 grams per vial, Rx only, Manufactured for: Civica Inc. Lehi Utah 84043, NDC 72572-058-10", "product_quantity": "124,010 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0686-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 4%/Dextrose 10%, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0408-1.", "product_quantity": "167 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-896130, Exp 05/06/2023; 37-897957, Exp 05/13/2023; 37-899605, Exp 05/20/2023; 37-901357, Exp 05/27/2023"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0724-2023", "product_description": "PHENYLephrine added to 0.9% sodium chloride, 40 mg/250 mL* (160 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6092-1.", "product_quantity": "14205 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883910, Exp 05/02/2023; 37-884221, Exp 05/03/2023; 37-884756, Exp 05/05/2023; 37-885358, Exp 05/08/2023; 37-885683, Exp 05/09/2023; 37-886267, 37-886268, Exp 05/11/2023; 37-886539, Exp 05/14/2023; 37-887458, 37-887459, Exp 05/16/2023; 37-888080, Exp 05/18/2023; 37-889192, Exp 05/23/2023; 37-889575, 37-889578, Exp 05/24/2023; 37-889852, 37-889855, Exp 05/25/2023; 37-890120, 37-890126, Exp 05/28/2023; 37-891485, 37-891491, Exp 06/01/2023; 37-892901, 37-892966, Exp 06/07/2023; 37-893236, 37-893237, Exp 06/08/2023; 37-893997, Exp 06/12/2023; 37-894777, Exp 06/14/2023; 37-895317, 37-895321, 37-895323, Exp 06/18/2023; 37-896201, Exp 06/20/2023; 37-896923, Exp 06/22/2023; 37-898558, Exp 06/29/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1049-2023", "product_description": "HYDROmorphone in dextrose 5%, 3 mg/30 mL, (0.1 mg/mL), 30 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2013-2", "product_quantity": "2,228 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270675, 17-270683, Exp. 7/18/2023; 17-271147, 17-271119, Exp. 7/25/2023; 17-271339, Exp. 7/27/2023; 17-271679, Exp. 8/2/2023; 17-272202, Exp. 8/10/2023; 17-272241, Exp. 8/13/2023; 17-272375, Exp. 8/15/2023; 17-272783, Exp. 8/22/2023; 17-273438, 17-273431, Exp. 9/3/2023; 17-273615, Exp. 9/5/2023; 17-273789, 9/7/2023."}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91977", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0528-2023", "product_description": "Dodex Injectable Cyanocobalamin Injection, USP 1,000 mcg/mL, 25 x1 ML Multiple dose vials, For Intramuscular or Subcutaneous Use Only, Rx Only, Sterile, Manufactured by: Intas Pharmaceuticals Limited Pharmaz Ahnedabad 382 213, INDIA, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, NDC 16729-533-08.", "product_quantity": "4574 cartons", "reason_for_recall": "Sub-potent drug: assay test result below specifications at 9-month timepoint.", "recall_initiation_date": "20230329", "center_classification_date": "20230406", "termination_date": "20250319", "report_date": "20230412", "code_info": "Lot #: R2200394 Exp. 03/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91921", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0481-2023", "product_description": "Glimepiride, USP, 2 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0488-30; b) 90-count bottle, NDC 61919-0448-90 Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534", "product_quantity": "30 count: 12 bottles; 90 count: 253 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230313", "center_classification_date": "20230324", "termination_date": "20240617", "report_date": "20230405", "code_info": "a) [30 count bottles] Lot, expiry:  21JU2112 , exp 9/30/2023   b) [90 count bottles] Lot, expiry: 22DE2113 , exp 1/31/2024;  27JA2235 , exp 3/31/2024;  05AP2224 , exp 7/31/2024 ;  06AU2104 , exp 1/31/2024 ;  08JU2215 , exp 9/30/2024 ;  209AU2109 , exp 1/31/2024 ;  15JU2113 , exp 9/30/2023 ;  21FE2217  , exp 4/30/2024 ;  21OC2115 , exp 2/29/2024 ;  23JY2144  , exp 1/31/2024 ;  25JU2124 , exp 9/30/2023 ;  29AP2219 , exp 7/31/2024 ;  07DE2128 , exp 3/31/2024 ."}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0217-2023", "product_description": "LEVEMIR-STS- 100U/ML (1ML VIAL) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221116@36", "more_code_info": ""}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202557"], "brand_name": ["BUSPIRONE HYDROCHLORIDE"], "generic_name": ["BUSPIRONE HYDROCHLORIDE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-200", "16729-203", "16729-289", "16729-201", "16729-202"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE"], "rxcui": ["866018", "866083", "866090", "866094", "866111"], "spl_id": ["4092e48b-b3d6-abf3-e063-6394a90afe61"], "spl_set_id": ["3da22999-f5fb-49fd-acde-c3006598e985"], "package_ndc": ["16729-203-12", "16729-203-01", "16729-203-59", "16729-203-16", "16729-203-17", "16729-289-12", "16729-289-01", "16729-289-59", "16729-289-16", "16729-289-17", "16729-200-01", "16729-200-16", "16729-200-17", "16729-201-01", "16729-201-16", "16729-201-17", "16729-202-01", "16729-202-16", "16729-202-17"], "is_original_packager": [true], "upc": ["0316729289016", "316729202169"], "unii": ["207LT9J9OC"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0378-2023", "product_description": "BusPIRone Hydrochloride Tablets USP, 10 mg 500-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA, NDC 16729-202-16 UPC 3 16729 20216 9", "product_quantity": "3,784 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2105472, Exp. Date 4/30/2024;", "more_code_info": ""}, {"status": "Ongoing", "city": "Carolina", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93159", "recalling_firm": "Omega & Delta Co., Inc.", "address_1": "Carr. 887 Km 0 Hm 8 Julio N. Matos Ind. Park Bldg#10", "address_2": "N/A", "postal_code": "00985", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed in Puerto Rico only.", "recall_number": "D-0105-2024", "product_description": "Equate Hand Sanitizer (Ethyl Alcohol 62%),  7.5 FL.OZ. (221 mL)  UPC 6 81131 05961 9", "product_quantity": "4,848 7.5 oz bottles", "reason_for_recall": "Sub Potent and Super Potent Product: During an impact assessment of the DOP Hand Sanitizer product, it was identified that several lots distributed did not comply with the finished good acceptance criteria established.", "recall_initiation_date": "20231020", "center_classification_date": "20231114", "report_date": "20231122", "code_info": "Lot #s 006511"}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200923"], "brand_name": ["GYNAZOLE 1"], "generic_name": ["BUTOCONAZOLE NITRATE"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "product_ndc": ["45802-396"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["VAGINAL"], "substance_name": ["BUTOCONAZOLE NITRATE"], "rxcui": ["890785", "890786"], "spl_id": ["3953738b-1476-4a24-9e07-a7d3866d76a8"], "spl_set_id": ["125d8ede-db38-4eb9-a6be-19208687f36a"], "package_ndc": ["45802-396-01", "45802-396-02"], "is_original_packager": [true], "unii": ["4805237NP5"]}, "product_type": "Drugs", "event_id": "93189", "recalling_firm": "Padagis US LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0081-2024", "product_description": "Gynazole-1, (Butoconazole Nitrate) Vaginal Cream USP, 2%, Net Wt 5.8 g per pre-filled applicator, packaged in 1 prefilled applicator per carton, Rx Only, Manufactured By Padagis, Yeruham, Israel; Distributed By: Padagis, Allegan, MI 49010.  NDC: 45802-396-01", "product_quantity": "10,512 cartons", "reason_for_recall": "Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing process.", "recall_initiation_date": "20230928", "center_classification_date": "20231031", "report_date": "20231108", "code_info": "Lot#: 164185, Exp. Date 4/2024"}, {"status": "Terminated", "city": "Indiana", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91980", "recalling_firm": "RemedyRepack Inc.", "address_1": "625 Kolter Dr Ste 4", "address_2": "", "postal_code": "15701-3571", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "RemedyRepack distributed product to consignees nationwide within the United States", "recall_number": "D-0503-2023", "product_description": "Simvastatin 40 mg tablets, packaged in a) 30-count bottles (NDC 70518-0060-01) and b) 90-count bottles (NDC 70518-0060-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701", "product_quantity": "", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20230320", "center_classification_date": "20230331", "termination_date": "20231019", "report_date": "20230412", "code_info": "Lot # a): J0656821-103122, Exp. Date 11/30/2023; J0638547-080922, Exp. Date 08/31/2023; J0633575-071822, Exp. Date 07/31/2023  Lot #: b): B1965081-111622, Exp. Date 03/31/2025; B1857922-091922, B1765298-071322, B1786319-072922, B1706842-053122, Exp. Date 04/30/2023; B2003311-120822, Exp. Date 04/30/2025; B1955679-111122, Exp. Date 02/28/2025; B1878942-092922, Exp. Date 11/30/2024; B1823203-082622. Exp. Date 10/31/2024; B1706843-053122, Exp. Date 05/31/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0707-2023", "product_description": "oxyTOCIN 30 units added to Lactated Ringer's 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-6039-1.", "product_quantity": "21871 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-889853, 37-889854, 37-889856, Exp 04/30/2023; 37-890087, 37-890088, 37-890095, 37-890098, 37-890100, 37-890107, 37-890109, Exp 05/03/2023; 37-890876, 37-890878, 37-890885, 37-890891, Exp 05/05/2023; 37-891572, Exp 05/07/2023; 37-892504, 37-892510, 37-892512, 37-892520, 37-892560, 37-892575, 37-892585, 37-892587, Exp 05/12/2023; 37-892988, 37-892989, Exp 05/13/2023; 37-894323, 37-894356, 37-894366, 37-894385, 37-894386, 37-894402, 37-894409, 37-894410, Exp 05/19/2023; 37-894778, Exp 05/20/2023; 37-894998, 37-894999, 37-895000, 37-895001, 37-895002, Exp 05/21/2023; 37-896186, 37-896189, 37-896192, 37-896194, 37-896200, 37-896202, 37-896227, 37-896231, 37-896240, 37-896241, Exp 05/26/2023; 37-896844, 37-896851, 37-896853, 37-896856, Exp 05/28/2023; 37-897827, 37-897836, 37-897837, 37-897853, 37-897854, 37-897928, Exp 06/02/2023; 37-900117, 37-900122, 37-900123, Exp 06/10/2023"}, {"status": "Ongoing", "city": "Wichita", "state": "KS", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93453", "recalling_firm": "Fagron Compounding Services", "address_1": "8710 E 34th St N", "address_2": "", "postal_code": "67226-2636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0125-2024", "product_description": "Tropicamide 1% (10mg/mL), Cyclopentolate 1% (10mg/mL), Phenylephrine 2.5% (25mg/mL), Ketorolac 0.5% (5mg/mL), 5 mL bottles, For Topical Ophthalmic Use Only, Not for IV Use, This is a Compounded Drug, Hospital & Office Use Only, Fagron Sterile Services, 8710 E 34th St N Wichita, KS 67226.  NDC 71266-8240-01", "product_quantity": "756 bottles", "reason_for_recall": "Labeling: Label Mix-Up: The label of a dropper bottle mistakenly states the container is a 0.5mL single-use syringe instead of a 5 mL dropper", "recall_initiation_date": "20231110", "center_classification_date": "20231128", "report_date": "20231206", "code_info": "Lot #:  C274-000033372, Exp. Date 01-17-2024; C274-000033764, Exp. Date 02-06-2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91952", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0512-2023", "product_description": "Atorvastatin Calcium Tablets, USP, 20 mg, packaged in: a) 90-count bottle (NDC 68788-7631-9); b) 30-count bottle (NDC 68788-7631-3), Rx only, Manufactured: Accord Healthcare, Inc., Durham, NC 27703", "product_quantity": "a) 375 Bottles b) 323 Bottles", "reason_for_recall": "cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.", "recall_initiation_date": "20230323", "center_classification_date": "20230406", "report_date": "20230412", "code_info": "a) Lot: B1522B, Exp 4/30/2023; lot:C0222H, C0322B, Exp 5/31/2023; lot: E1022H, F13220, H2222P, Exp 6/30/2023; Lot: I1422V, K01220, Exp 12/31/2023; Lot: L2722H, Exp 3/31/2024; b) Lot:C0322B, Exp 5/31/2023; lot:H1122G, 12322Q, Exp 6/30/2023; lot: J1222U, Exp 12/31/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0598-2023", "product_description": "Ampicillin and Sulbactam for Injection, USP 15 grams per Pharmacy Bulk Package, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017 USA, NDC 66794-208-15", "product_quantity": "11,555 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Woodbine", "state": "IA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "93354", "recalling_firm": "Grato Holdings, Inc.", "address_1": "201 Apple Blvd", "address_2": "", "postal_code": "51579-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Distributed to one direct account in Florida with possible further distribution out of state.", "recall_number": "D-0099-2024", "product_description": "V-FORCE Homeopathic, 1 FL OZ (30 ml) per glass bottle, Distributed by:  BioActive Nutritional, Inc., 1803 N. Wickham Rd., Melbourne, FL 32935", "product_quantity": "1,333 30mL bottles", "reason_for_recall": "Incorrect Product Formulation: product contains Active Ingredient Glandula Suprarenalis Suis 8X instead of Glandula Suprarenalis Bovine 8X (as stated on the product label).", "recall_initiation_date": "20231030", "center_classification_date": "20231109", "termination_date": "20240512", "report_date": "20231115", "code_info": "Lot: Z65842 no exp date on product", "more_code_info": ""}, {"status": "Terminated", "city": "Xiamen", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91410", "recalling_firm": "GFA Production Xiamen Co. Ltd.", "address_1": "Huli Industrial Park No. 20", "address_2": "Meixi Road; Tong'An", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Canada.", "recall_number": "D-0248-2023", "product_description": "Easy Care First Aid 25 Person 2009 ANSI, First Aid Kit, containing Easy Care first aid After Burn Cream 0.9 g packets, Product # 9999-2129", "product_quantity": "37464 packets", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.", "recall_initiation_date": "20221223", "center_classification_date": "20230127", "termination_date": "20250729", "report_date": "20230208", "code_info": "Lot # W05L28, exp 12/28/2023"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0188-2023", "product_description": "Methylcobalamin 1MG/ML (1ML vial); Methylcobalamin 3MG/ML (1ML vial); Methylcobalamin 5MG/ML (1ML vial) INJECTABLE, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "t20221021@36 t20221025@32 t20221025@33", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0312-2023", "product_description": "ONDANSETRON 8MG IN NS 100ML, antimetic, Rx Only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "15 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 29-30, 2022"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1061-2023", "product_description": "fentaNYL in 0.9% sodium chloride, 2500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-5", "product_quantity": "8,146 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270584, 17-270586, 17-270597, 17-270613, Exp. 7/17/2023; 17-270655, 17-270659, 17-270741, Exp. 7/18/2023; 17-270872, 17-270875, Exp. 7/20/2023; 17-271040, 17-271041, 17-271042, 17-271058, 17-271066, 17-271071, 17-271080, Exp. 7/24/2023; 17-271111, 17-271148, 17-271150, 17-271151, 17-271152, 17-271166, Exp. 7/25/2023; 17-271241, 17-271267, Exp. 7/26/2023; 17-271402, 17-271407, 17-271413, 17-271429, Exp. 7/30/2023; 17-271555, 17-271556, 17-271560, 17-271594, Exp. 8/1/2023; 17-271754, Exp. 8/3/2023; 17-271797, 17-271799, 17-271821, 17-271842, Exp. 8/6/2023; 17-271888, 17-271889, Exp. 8/7/2023; 17-271949, 17-271950, Exp. 8/8/2023; 17-272021, 17-272041, Exp. 8/9/2023; 17-272285, 17-272292, 17-272309, 17-272316, Exp. 8/14/2023; 17-272705, 17-272708, 17-272709, 17-272722, 17-272725, Exp. 8/21/2023; 17-272784, 17-272810, Exp. 8/22/2023; 17-272916, Exp. 8/23/2023; 17-272981, 17-272982, 17-272983, 17-272984, Exp. 8/24/2023; 17-273144, 17-273145, 17-273158, 17-273159, 17-273165, Exp. 8/29/2023; 17-273480, 17-273485, 17-273492, 17-273494, 17-273498, Exp. 9/4/2023; 17-273567, 17-273568, 17-273578, 17-273603, Exp. 9/5/2023; 17-273767, 17-273777, 17-273781, Exp. 9/7/2023; 17-273980, Exp. 9/11/2023; 17-274130, 17-274135, Exp. 9/13/2023."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0734-2023", "product_description": "NORepinephrine added to 0.9% sodium chloride, 16 mg/250 mL* (64 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 71285-7036-1.", "product_quantity": "6341 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-882998, 37-883005, 37-883145, Exp 04/28/2023; 37-883144, 37-883220, 37-883221, 37-883222, Exp 04/30/2023; 37-883925, Exp 05/02/2023; 37-884180, 37-884181, Exp 05/03/2023; 37-884505, 37-884506, 37-884507, 37-884508, 37-884509, Exp 05/04/2023; 37-884834, 37-884869, 37-884870, Exp 05/07/2023; 37-886058, Exp 05/10/2023; 37-886536, 37-886537, Exp 05/14/2023; 37-887062, 37-887389, Exp 05/15/2023; 37-887784, 37-887787, Exp 05/17/2023; 37-888029, 37-888048, Exp 05/18/2023; 37-888261, 37-888263, 37-888269, 37-888282, 37-888292, 37-888294, 37-888301, 37-888302, Exp 05/21/2023; 37-890058, 37-890064, 37-890074, 37-890076, Exp 05/28/2023; 37-891747, 37-891748, 37-891750, 37-891751, 37-891753, Exp 06/04/2023; 37-893530, 37-893531, 37-893532, Exp 06/11/2023; 37-894760, 37-894761, Exp 06/14/2023; 37-894988, 37-894990, Exp 06/15/2023; 37-896260, Exp 06/20/2023; 37-896621, Exp 06/21/2023; 37-898518, 37-898519, Exp 06/29/2023; 37-898789, 37-898790, 37-898791, 37-898792, 37-898793, Exp 07/02/2023; 37-899718, Exp 07/04/2023; 37-900591, 37-900596, Exp 07/09/2023; 37-901149, Exp 07/10/2023"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0279-2023", "product_description": "CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1.5ML SYR, antibiotic, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "8 syringes", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 29-31, 2022"}, {"status": "Terminated", "city": "Miramar", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91712", "recalling_firm": "AVEVA Drug Delivery Systems, Inc.", "address_1": "3250 Commerce Pkwy", "address_2": "N/A", "postal_code": "33025-3907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0466-2023", "product_description": "Buprenorphine Transdermal System, CIII 20 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC  60505-7079-05", "product_quantity": "5,208 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.", "recall_initiation_date": "20230215", "center_classification_date": "20230314", "termination_date": "20240430", "report_date": "20230322", "code_info": "Lot#: 51836 Exp: 07/2023"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0784-2023", "product_description": "Apraclonidine Ophthalmic Solution 0.5%, packaged in a) 5mL and b) 10 mL bottles, Rx only, Sterile, For Topical Ophthalmic Use Only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090509"], "brand_name": ["TACROLIMUS"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-525", "55111-526", "55111-527"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["198377", "198378", "313190"], "spl_id": ["706bafff-d629-291c-5ce5-83d74a638860"], "spl_set_id": ["61dee012-43af-0e9a-3843-9b9b91e022c4"], "package_ndc": ["55111-525-30", "55111-525-01", "55111-525-05", "55111-525-79", "55111-525-78", "55111-526-30", "55111-526-01", "55111-526-05", "55111-526-79", "55111-526-78", "55111-527-30", "55111-527-01", "55111-527-05", "55111-527-79", "55111-527-78"], "is_original_packager": [true], "upc": ["0355111527015", "0355111525011", "0355111526018"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "91661", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0330-2023", "product_description": "Tacrolimus Capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Mfd. by Dr. Reddy's Laboratories Limited, Bachupally - 500 090, INDIA; NDC 55111-525-01.", "product_quantity": "4,320 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules.", "recall_initiation_date": "20230208", "center_classification_date": "20230221", "report_date": "20230301", "code_info": "Lot # C2106445; Exp. 03/2024"}, {"status": "Terminated", "city": "Yonkers", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["SNORESTOP NASOSPRAY 60"], "generic_name": ["STRYCHNOS NUX-VOMICA SEED,ATROPA BELLADONNA,EPHEDRA DISTACHYA FLOWERING TWIG,GOLDENSEAL,POTASSIUM DICHROMATE,TEUCRIUM MARUM,HISTAMINE DIHYDROCHLORIDE LIQUID"], "manufacturer_name": ["Green Pharmaceuticals Inc."], "product_ndc": ["61152-199"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["ATROPA BELLADONNA", "EPHEDRA DISTACHYA FLOWERING TWIG", "GOLDENSEAL", "N.ALPHA.-METHYLHISTAMINE DIHYDROCHLORIDE", "POTASSIUM DICHROMATE", "STRYCHNOS NUX-VOMICA SEED", "TEUCRIUM MARUM"], "spl_id": ["e194696f-0a7f-f303-e053-2a95a90a3c90"], "spl_set_id": ["f4d26053-32aa-4cc9-8460-556acc38fe33"], "package_ndc": ["61152-199-99"], "is_original_packager": [true], "nui": ["N0000185375", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0016962", "M0516536"], "pharm_class_epc": ["Non-Standardized Plant Allergenic Extract [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Plant Proteins [CS]", "Seed Storage Proteins [CS]"], "unii": ["WQZ3G9PF0H", "R55VQ87DP3", "ZW3Z11D0JV", "S6S98U0517", "T4423S18FM", "269XH13919", "10464S0TAA"]}, "product_type": "Drugs", "event_id": "92453", "recalling_firm": "Homeocare Laboratories, Inc.", "address_1": "7 Odell Plz Ste 142-146", "address_2": "N/A", "postal_code": "10701-1407", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed USA nationwide.", "recall_number": "D-0885-2023", "product_description": "SnoreStop Naso Spray Bulk, liquid, Distributed by Green Pharma, NDC 61152-199-99", "product_quantity": "200 liters/55 gallon drum", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230605", "center_classification_date": "20230626", "termination_date": "20240916", "report_date": "20230705", "code_info": "Lot # 2436, exp. date: unknown", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1067-2023", "product_description": "fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2", "product_quantity": "1,486 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270811, Exp. 7/19/2023; 17-270954, 17-270983, Exp. 7/23/2023; 17-271231, Exp. 7/26/2023; 17-271690, Exp. 8/2/2023; 17-272204, Exp. 8/13/2023; 17-272684, Exp. 8/20/2023; 17-272992, Exp. 8/24/2023; 17-273053, Exp. 8/28/2023; 17-273436, Exp. 9/3/2023."}, {"status": "Terminated", "city": "Anaheim", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92008", "recalling_firm": "Preferred Pharmaceuticals, Inc.", "address_1": "1250 N Lakeview Ave Ste O", "address_2": "", "postal_code": "92807-1801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0506-2023", "product_description": "Alprazolam Tab, USP 1mg, (CIV), packaged in: a) 30-count bottle (NDC 68788-7596-3), b) 60-count bottle (NDC68788-7596-6); Rx Only, Preferred Pharmaceuticals, Inc. Manufactured by: Breckenridge Pharmaceuticals, Inc., Boca Raton, FL.", "product_quantity": "33 x 30-count; 78 x 60-count bottles", "reason_for_recall": "CGMP Deviations: Downstream recall from Breckenridge Pharmaceuticals, Inc due to potential risk of Cross Contamination.", "recall_initiation_date": "20230327", "center_classification_date": "20230405", "termination_date": "20231024", "report_date": "20230412", "code_info": "Lot # a) H3122D, Exp. Date:8/31/2024; b) Lot #A1123R, L0522E, J2622H, I1622F, H2422E, Exp. Date:8/31/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "West Sacramento", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "92203", "recalling_firm": "Gadget Island, Inc", "address_1": "1275 Halyard Dr Ste 175", "address_2": "", "postal_code": "95691", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0573-2023", "product_description": "DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC 6 75799 37602 7.", "product_quantity": "140 blister packs", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20230426", "center_classification_date": "20230511", "report_date": "20230510", "code_info": "Lot/Item#: OMS760-B, Exp: 12/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91921", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0479-2023", "product_description": "Ropinirole, USP, 1 mg Tablets, Rx Only, Packaged as a 30-count bottle, NDC 72189-0364-30; Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534", "product_quantity": "4 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230313", "center_classification_date": "20230324", "termination_date": "20240617", "report_date": "20230405", "code_info": "Lot, expiry:  22JU2216 , exp 8/31/23"}, {"status": "Terminated", "city": "Newark", "state": "DE", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "92120", "recalling_firm": "DuPont Nutrition USA, Inc", "address_1": "1301 Ogletown Rd", "address_2": "N/A", "postal_code": "19711-5419", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Malta, Canada, China, Peru, Mexico, Australia, Saudi Arabia, Spain, Dominican Republic, Puerto Rico, Singapore, Bangkok, Ireland, India, and Columbia.", "recall_number": "D-0546-2023", "product_description": "Avicel PH-200 NF, Microcrystalline Cellulose NF, Net Content/Gross Weight 20.0 KG / 21.1 KG bulk container, Manufactured by: DuPont Nutrition USA, Inc., 1301 Ogletown Road, Newark, DE 19711, USA; Manufactured in USA; Headquarters: DuPont Nutrition Biosciences ApS, Langebrogade 1, Copenhagen, Denmark.", "product_quantity": "93,660 kg in bulk drums, boxes & sacks", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.", "recall_initiation_date": "20230413", "center_classification_date": "20230425", "termination_date": "20240304", "report_date": "20230503", "code_info": "Batch Numbers: 2173766945, 2173768895, PN20834306, 217373201, PN20834301"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0780-2023", "product_description": "Acetaminophen & Codeine Phosphate Oral Solution 120mg/12mg/5mL, packaged in a) 473mL bottles and b) 40 UD cups, Rx only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0687-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 5% with CALCIUM, packaged in 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0413-1.", "product_quantity": "258 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-894313, Exp 04/29/2023; 37-895257, Exp 05/04/2023; 37-897360, Exp 05/12/2023; 37-897890, Exp 05/13/2023; 37-900964, Exp 05/26/2023"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0313-2023", "product_description": "PANTOPRAZOLE 30MG IN NS 7.5ML, SYRINGE, antimetic, Rx only, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "14 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 29, 2022"}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207687"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Northwind Pharmaceuticals, LLC"], "product_ndc": ["51655-946"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["617312"], "spl_id": ["2a344dd4-cd7d-c3f5-e063-6294a90a23f2"], "spl_set_id": ["df6233cf-5b4e-5fbe-e053-2a95a90a0a80"], "package_ndc": ["51655-946-52"], "original_packager_product_ndc": ["16729-044"], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "91944", "recalling_firm": "Northwind Pharmaceuticals LLC", "address_1": "4838 Fletcher Ave Ste 1000", "address_2": "N/A", "postal_code": "46203-1642", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide with the United States", "recall_number": "D-0548-2023", "product_description": "Atorvastatin Calcium Tablets, USP, 10 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203.  NDC 51655-946-52", "product_quantity": "99 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230316", "center_classification_date": "20230426", "report_date": "20230503", "code_info": "Lot # F117192201, Exp. Date 4/30/2023"}, {"status": "Terminated", "city": "Miramar", "state": "FL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "91712", "recalling_firm": "AVEVA Drug Delivery Systems, Inc.", "address_1": "3250 Commerce Pkwy", "address_2": "N/A", "postal_code": "33025-3907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0465-2023", "product_description": "Buprenorphine Transdermal System, CIII 10 mcg/hour, 4 Transdermal Systems One package of 4 disposal units, Rx Only, Manufactured by: Aveva Drug Delivery Systems Inc. Miramar, FL. 33025, Manufactured for: Apotex Corp Weston, FL. 33326, NDC 60505-7077-05", "product_quantity": "11,520 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.", "recall_initiation_date": "20230215", "center_classification_date": "20230314", "termination_date": "20240430", "report_date": "20230322", "code_info": "Lot#: 51835 Exp: 06/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1055-2023", "product_description": "HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2", "product_quantity": "2,389 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-270530, Exp. 7/16/2023; 17-270871, Exp. 7/20/2023; 17-271153, Exp. 7/25/2023; 17-271275, Exp. 7/26/2023; 17-271417, Exp. 7/30/2023; 17-271671, Exp. 8/2/2023; 17-271883, Exp. 8/7/2023; 17-271992, Exp. 8/8/2023; 17-272050, Exp. 8/9/2023; 17-272103, Exp. 8/10/2023; 17-272368, 17-272369, Exp. 8/15/2023; 17-272451, Exp. 8/16/2023; 17-273172, Exp. 8/29/2023; 17-273782, Exp. 9/7/2023."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0824-2023", "product_description": "Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100mL tubes, Rx Only, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Brampton", "state": "", "country": "Canada", "classification": "Class III", "openfda": {"application_number": ["ANDA088759"], "brand_name": ["HYDROCORTISONE AND ACETIC ACID"], "generic_name": ["HYDROCORTISONE AND ACETIC ACID"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-3007"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["AURICULAR (OTIC)"], "substance_name": ["ACETIC ACID", "HYDROCORTISONE"], "spl_id": ["395a20ab-856b-3f08-e063-6294a90aa48e"], "spl_set_id": ["6383c722-84e2-4719-a13d-19c54e3eefff"], "package_ndc": ["51672-3007-1"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q40Q9N063P", "WI4X0X7BPJ"]}, "product_type": "Drugs", "event_id": "93337", "recalling_firm": "Taro Pharmaceuticals Inc.", "address_1": "130 East Dr", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0089-2024", "product_description": "Hydrocortisone 1% and Acetic Acid 2% Otic Solution USP, 10ml dropper bottle, RX Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada LGT 1C, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532. NDC 51672-3007-1", "product_quantity": "11,196 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications:Out-of-Specification result for Hydrocortisone related impurity and slightly lower than the established level of the Hydrocortisone Assay obtained during stability testing.", "recall_initiation_date": "20231106", "center_classification_date": "20231106", "termination_date": "20240827", "report_date": "20231115", "code_info": "Lot# AC86809, AC86812, Exp Date: 01/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0823-2023", "product_description": "Lidocaine HCl Jelly USP, 2%, 5mL tubes, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92898", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1137-2023", "product_description": "dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride,  IV Bag, Rx Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Phoenix, AZ 85043, NDC: 72196-6055-1", "product_quantity": "235 bags", "reason_for_recall": "Lack of Assurance of Sterility:Lack of validation data for sanitization cycles", "recall_initiation_date": "20230817", "center_classification_date": "20230828", "termination_date": "20250327", "report_date": "20230906", "code_info": "Lot# 36-262537, Exp 9/19/2023.                 ;"}, {"status": "Ongoing", "city": "Amman", "state": "", "country": "Jordan", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92974", "recalling_firm": "AMMAN PHARMACEUTICAL INDUSTRIES", "address_1": "Building 108", "address_2": "Street A3, King Abdullah Ii Industrial City", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to two (2) direct accounts in RI and CO.", "recall_number": "D-1163-2023", "product_description": "TRP Natural Eyes, Red Eye Relief, Sterile Eye drops, Homeopathic 0.33 FL OZ (10 mL), Manufactured in Jordan, exclusively for TRP Company, Inc., 1575 Delucchi Lane, Reno, NV 89502, NDC: 17312-058-15.", "product_quantity": "8,868 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230901", "center_classification_date": "20230915", "report_date": "20230927", "code_info": "Lot: FQ001 EXP:07/24", "more_code_info": ""}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022014"], "brand_name": ["EVAMIST"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Padagis US LLC"], "product_ndc": ["0574-2067"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["728118", "728122"], "spl_id": ["2da3b881-d6b1-4996-889b-cd882108af38"], "spl_set_id": ["9a0aa631-133d-406b-9d32-8a1a99af4e50"], "package_ndc": ["0574-2067-27", "0574-2067-00"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "91771", "recalling_firm": "Padagis US LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0464-2023", "product_description": "Evamist (estradiol transdermal spray), 1.53 mg of estradiol per spray, 0.27 fl oz (8.1 mL) per metered-dose pump, Rx Only, Manufactured by DPT Laboratories, Ltd San Antonio, TX 78215, Manufactured for: Perrigo, Allegan, Minnapolis, MN 55427,  NDC: 0574-2067-27", "product_quantity": "43,238 cartons", "reason_for_recall": "Failed Content Uniformity Specifications: The Spray Content Uniformity (SCU) requirement for Standard Deviation did not meet the requirement at the 18-month stability time point.", "recall_initiation_date": "20230221", "center_classification_date": "20230310", "report_date": "20230322", "code_info": "Lot# SCDR, Exp 02/2024"}, {"status": "Ongoing", "city": "West Sacramento", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "92203", "recalling_firm": "Gadget Island, Inc", "address_1": "1275 Halyard Dr Ste 175", "address_2": "", "postal_code": "95691", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0571-2023", "product_description": "Pro Power Knight Plus capsule, 2550mg, 1-count blister card, Distributed by Beyond Health and youth Inc, Seattle, WA  98110, UPC 4 94922 90522 0.", "product_quantity": "628 blister cards", "reason_for_recall": "Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20230426", "center_classification_date": "20230511", "report_date": "20230510", "code_info": "No lot number, Exp: 06/2026", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA206977"], "brand_name": ["TIROSINT"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["IBSA Pharma Inc."], "product_ndc": ["71858-0105", "71858-0110", "71858-0112", "71858-0113", "71858-0115", "71858-0117", "71858-0120", "71858-0125", "71858-0130", "71858-0135", "71858-0140", "71858-0145", "71858-0150", "71858-0155", "71858-0160"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["2056462", "2056466", "2056468", "2056470", "2056472", "2056474", "2056476", "2056478", "2056480", "2056482", "2056484", "2056486", "2056488", "2056490", "2056492", "2056494", "2056496", "2056498", "2056500", "2056502", "2056504", "2056506", "2056508", "2056510", "2566608", "2566610", "2566613", "2566615", "2566617", "2566619"], "spl_id": ["2c23d44e-1a15-f636-e063-6294a90a0ed4"], "spl_set_id": ["5d378add-f13d-40f2-99dc-0f2340ab44b7"], "package_ndc": ["71858-0105-6", "71858-0105-4", "71858-0105-5", "71858-0105-1", "71858-0105-2", "71858-0110-6", "71858-0110-4", "71858-0110-5", "71858-0110-1", "71858-0110-2", "71858-0112-6", "71858-0112-4", "71858-0112-5", "71858-0112-1", "71858-0112-2", "71858-0113-6", "71858-0113-4", "71858-0113-5", "71858-0113-1", "71858-0113-2", "71858-0115-6", "71858-0115-4", "71858-0115-5", "71858-0115-1", "71858-0115-2", "71858-0117-6", "71858-0117-4", "71858-0117-5", "71858-0117-1", "71858-0117-2", "71858-0120-6", "71858-0120-4", "71858-0120-5", "71858-0120-1", "71858-0120-2", "71858-0125-6", "71858-0125-4", "71858-0125-5", "71858-0125-1", "71858-0125-2", "71858-0130-6", "71858-0130-4", "71858-0130-5", "71858-0130-1", "71858-0130-2", "71858-0135-6", "71858-0135-4", "71858-0135-5", "71858-0135-1", "71858-0135-2", "71858-0140-6", "71858-0140-4", "71858-0140-5", "71858-0140-1", "71858-0140-2", "71858-0145-6", "71858-0145-4", "71858-0145-5", "71858-0145-1", "71858-0145-2", "71858-0150-6", "71858-0150-4", "71858-0150-5", "71858-0150-1", "71858-0150-2", "71858-0155-6", "71858-0155-4", "71858-0155-5", "71858-0155-1", "71858-0155-2", "71858-0160-6", "71858-0160-4", "71858-0160-5", "71858-0160-1", "71858-0160-2"], "is_original_packager": [true], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91556", "recalling_firm": "IBSA PHARMA INC", "address_1": "8 Campus Dr Ste 201", "address_2": "N/A", "postal_code": "07054-4409", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0334-2023", "product_description": "TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL;  6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0155-5", "product_quantity": "N/A", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20230130", "center_classification_date": "20230404", "termination_date": "20231031", "report_date": "20230301", "code_info": "Lot #: 220416, Exp. 10/2023; 221053, Exp. 4/2024."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0816-2023", "product_description": "Levetiracetam Oral Solution 100 mg/mL (100 mg/mL), 473 mL, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Cresson", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93199", "recalling_firm": "Integrity Bio-Chemicals LLC", "address_1": "1100 N Cresson Hwy", "address_2": "N/A", "postal_code": "76035-4121", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed to one distributor in OK with possibility of further distribution", "recall_number": "D-0109-2024", "product_description": "Integrity Biochem HSC 70-LM, Alcohol Antiseptic 70%, Hand Sanitizer, Lemon Scented Topical Gel, 208.19 L (55 gallons) drum, Integrity Biochem, 1100 North Cresson Hwy, Cresson, TX 76035. Made in the USA NDC: 77512-044-03", "product_quantity": "1 55-gallon drum", "reason_for_recall": "CGMP Deviation: Third party test results showing a presence of acetal and acetaldehyde at levels above USP specified amounts.", "recall_initiation_date": "20231018", "center_classification_date": "20231120", "termination_date": "20250321", "report_date": "20231129", "code_info": "Lot #:  2133607, Manufacturing Date 11/23/2021 No Exp date on label.", "more_code_info": ""}, {"status": "Ongoing", "city": "Carolina", "state": "PR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93159", "recalling_firm": "Omega & Delta Co., Inc.", "address_1": "Carr. 887 Km 0 Hm 8 Julio N. Matos Ind. Park Bldg#10", "address_2": "N/A", "postal_code": "00985", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed in Puerto Rico only.", "recall_number": "D-0104-2024", "product_description": "DOP Instant Hand Sanitizer (Ethyl Alcohol 65%) with Moisturizers, 8FL OZ (237mL) bottle, Hecho en Puerto Rico por: Omega & Delta Co., Inc. UPC 7 42699 00030 4", "product_quantity": "23,136 8 OZ bottles", "reason_for_recall": "Sub Potent and Super Potent Product: During an impact assessment of the DOP Hand Sanitizer product, it was identified that several lots distributed did not comply with the finished good acceptance criteria established.", "recall_initiation_date": "20231020", "center_classification_date": "20231114", "report_date": "20231122", "code_info": "Lot #s  1113005, 1116005, 0237088, 0232084, 012764, 012864, 0244096, 0245096."}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208040"], "brand_name": ["DABIGATRAN ETEXILATE"], "generic_name": ["DABIGATRAN ETEXILATE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-474", "67877-475", "67877-624"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DABIGATRAN ETEXILATE MESYLATE"], "rxcui": ["1037045", "1037179", "1723476"], "spl_id": ["dd84fc7b-8d68-4a2b-ab48-9458f6586160"], "spl_set_id": ["3a8ec82a-c367-40dc-9302-e1896fcb05ea"], "package_ndc": ["67877-475-60", "67877-474-60", "67877-624-60", "67877-624-31"], "is_original_packager": [true], "unii": ["SC7NUW5IIT"]}, "product_type": "Drugs", "event_id": "91880", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0534-2023", "product_description": "Dabigatran Etexilate 150mg Capsules, 150 mg, Rx Only, 60 Capsules per bottle, Manufactured by:  Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC 67877-475-60.", "product_quantity": "12,804 bottles", "reason_for_recall": "CGMP Deviations: Detection of N-nitroso-dabigatran (NDAB) impurity levels above the Acceptable Daily Intake Limit.", "recall_initiation_date": "20230314", "center_classification_date": "20230413", "report_date": "20230405", "code_info": "Lot #s: 22142448, 22142449, 22142450, Exp 5/2024; 22143845, Exp 7/2024."}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0591-2023", "product_description": "Ampicillin and Sulbactam for Injection, USP 3 gram per vial, Rx only, Manufactured for: Civica Inc. Lehi Utah 84043, NDC 72572-022-10", "product_quantity": "419,680 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0654-2023", "product_description": "Cardioplegia Solution, Reperfusate 4:1 low potassium/low tromethamine, 15 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0009-1.", "product_quantity": "254 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-893848, Exp 04/28/2023; 37-895681, Exp 05/05/2023; 37-899250, Exp 05/19/2023; 37-901355, Exp 05/27/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0022-2024", "product_description": "fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 100 mL bag, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-4", "product_quantity": "240 100 mL bags", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275704, Exp. 10/9/2023."}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078314"], "brand_name": ["NAPROXEN SODIUM"], "generic_name": ["NAPROXEN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-178", "68462-188", "68462-189", "68462-190", "68462-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NAPROXEN SODIUM"], "rxcui": ["198012", "198013", "198014", "849398", "849431"], "spl_id": ["b7cce793-fe49-4fe0-8848-fc89f7ea3832"], "spl_set_id": ["6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"], "package_ndc": ["68462-188-01", "68462-188-05", "68462-189-01", "68462-189-05", "68462-190-30", "68462-190-50", "68462-190-01", "68462-190-05", "68462-178-01", "68462-178-05", "68462-179-01", "68462-179-05"], "is_original_packager": [true], "upc": ["0368462190012", "0368462179017", "0368462178010", "0368462189016", "0368462188019"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["9TN87S3A3C", "57Y76R9ATQ"]}, "product_type": "Drugs", "event_id": "93368", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0124-2024", "product_description": "Naproxen Tablets, USP 250mg, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Colvale-Bardez, Goa 403513, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-188-01.", "product_quantity": "", "reason_for_recall": "Labeling: Label Mix-Up-Indomethacin bottles may be labeled as Naproxen", "recall_initiation_date": "20231107", "center_classification_date": "20231127", "report_date": "20231206", "code_info": "Lot# 19231903; Exp 4/2025 Lot# 19231858; Exp 4/2025 Lot# 19231881; Exp 4/2025 Lot# 19233484: Exp 8/2025 Lot# 19233490; Exp 8/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1005-2023", "product_description": "Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with **low calcium** and HEPARIN, IV Bag, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0429-1", "product_quantity": "304 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-251203, Exp. 7/10/2023; 36-254924, Exp. 7/22/2023."}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90948", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0135-2023", "product_description": "Betaxolol Ophthalmic Solution, USP 0.5%,  (Betaxolol HCl 5.6 mg/mL), 5 mL per bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  NDC: 17478-705-10", "product_quantity": "6,273 bottles", "reason_for_recall": "CGMP Deviations:", "recall_initiation_date": "20221013", "center_classification_date": "20230113", "report_date": "20230125", "code_info": "Lot: 1A08A, EXP 12/31/2022"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0976-2023", "product_description": "oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6043-1", "product_quantity": "6037 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239496, Exp. 7/12/2023; 36-240256, Exp. 7/17/2023; 36-241134, Exp. 7/19/2023; 36-241928, Exp. 7/23/2023; 36-243835, Exp. 7/31/2023; 36-245010, 36-245011, Exp. 8/1/2023; 36-245529, 36-245532, Exp. 8/2/2023; 36-246255, 36-246256, 36-246258, 36-246259, Exp. 8/3/2023; 36-247806, Exp. 8/9/2023; 36-248035, Exp. 8/10/2023; 36-248367, Exp. 8/11/2023; 36-249506, 36-249507, 36-249508, Exp. 8/18/2023; 36-251436, 36-251437, Exp. 8/28/2023; 36-254396, Exp. 9/4/2023"}, {"status": "Terminated", "city": "New Castle", "state": "DE", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "92950", "recalling_firm": "Marlex Pharmaceuticals, Inc.", "address_1": "65 Lukens Dr", "address_2": "N/A", "postal_code": "19720-2718", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US.", "recall_number": "D-1169-2023", "product_description": "Digoxin Tablets, USP  0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01", "product_quantity": "94/100 count bottles", "reason_for_recall": "Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.", "recall_initiation_date": "20230825", "center_classification_date": "20230918", "termination_date": "20240417", "report_date": "20230913", "code_info": "Lot # E3810, expiration date 02/2025"}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA212400"], "brand_name": ["TRIAMCINOLONE ACETONIDE"], "generic_name": ["TRIAMCINOLONE ACETONIDE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-384", "55150-385"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR", "INTRAMUSCULAR", "SOFT TISSUE"], "substance_name": ["TRIAMCINOLONE ACETONIDE"], "rxcui": ["1085754"], "spl_id": ["dab18c1a-6fc9-4427-b44f-e34e0168450e"], "spl_set_id": ["d9abdda5-80e3-407c-b636-9cc5fc438098"], "package_ndc": ["55150-384-01", "55150-385-01"], "is_original_packager": [true], "upc": ["0355150384013", "0355150385010"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["F446C597KA"]}, "product_type": "Drugs", "event_id": "93128", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0041-2024", "product_description": "Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.", "product_quantity": "1,626 vials", "reason_for_recall": "Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.", "recall_initiation_date": "20230928", "center_classification_date": "20231005", "report_date": "20231011", "code_info": "Lot #: 3TC22010, Exp 11/30/2024"}, {"status": "Terminated", "city": "Erie", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91332", "recalling_firm": "Pharmacy Innovations", "address_1": "2936 W 17th St", "address_2": "N/A", "postal_code": "16505-3929", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0185-2023", "product_description": "Dutasteride 0.1% (1.5ML VIAL) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.", "recall_initiation_date": "20221222", "center_classification_date": "20230126", "termination_date": "20240731", "report_date": "20230201", "code_info": "20221012@21 t20221025@32 t20221109@7", "more_code_info": ""}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0121-2023", "product_description": "TriMix Injection (PGE1/Papaverine HCl/Phentolamine) 100mcg/30mg/2mg/mL INJECTABLE, packaged in 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "8 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11252022@15, Exp 1/9/2023; 11302022@9, Exp 1/14/2023; 12022022@5, Exp 1/16/2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0845-2023", "product_description": "Sodium Chloride Ophthalmic Solution, USP, 5%, 50mg/mL, 15 mL bottles, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204022"], "brand_name": ["ROPINIROLE"], "generic_name": ["ROPINIROLE"], "manufacturer_name": ["Accord Healthcare Inc."], "product_ndc": ["16729-232", "16729-233", "16729-234", "16729-235", "16729-236", "16729-237", "16729-238"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ROPINIROLE HYDROCHLORIDE"], "rxcui": ["283858", "312845", "312846", "312847", "312849", "314208", "562704"], "spl_id": ["23980eef-2eb5-2b74-e063-6394a90a68ac"], "spl_set_id": ["4a2a5b63-5b14-6975-e054-00144ff8d46c"], "package_ndc": ["16729-232-01", "16729-233-01", "16729-234-01", "16729-235-01", "16729-236-01", "16729-237-01", "16729-238-01"], "is_original_packager": [true], "unii": ["D7ZD41RZI9"], "upc": ["316729238014"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0431-2023", "product_description": "rOPINIRole Tablets USP 5 mg* 100-count bottle, Rx Only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703 Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA, NDC 16729-238-01, UPC 3 16729 23801 4", "product_quantity": "5,112 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2104150, P2104151, Exp. Date 6/30/2023, P2202065, Exp. Date 3/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Santa Ana", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91498", "recalling_firm": "McGuff Compounding Pharmacy Services, Inc.", "address_1": "2921 W Macarthur Blvd Ste 142", "address_2": "N/A", "postal_code": "92704-7944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0267-2023", "product_description": "Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL), Riboflavin 30 mg/30 mL (1mg/mL) Injection, FOR INTRAMUSCULAR OR SLOW INTRAVENOUS USE, 30 mL Sterile Multiple Use Vial, Rx Only, Compounded for a licensed professional or patient use by: McGuff Compounding Pharmacy Services, Inc, Santa Ana, CA 92704.", "product_quantity": "255 vials", "reason_for_recall": "Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.", "recall_initiation_date": "20221208", "center_classification_date": "20230210", "termination_date": "20230427", "report_date": "20230222", "code_info": "Lot: 22K1661, initial BUD: 12/18/2022, extended BUD: 1/27/2023; 22J2401, BUD: 12/19/2022."}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0973-2023", "product_description": "oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6042-1", "product_quantity": "3821 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-241662, Exp. 7/20/2023; 36-242725, Exp. 7/26/2023; 36-243607, Exp. 7/30/2023; 36-243837, 36-243838, Exp. 7/31/2023; 36-245517, 36-245523, 36-245525, 36-245662, Exp. 8/2/2023; 36-247254, 36-247255, Exp. 8/8/2023; 36-247983, Exp. 8/10/2023; 36-254917, Exp. 9/5/2023"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0791-2023", "product_description": "Cetrorelix Acetate for Injection, 0.25 mg, , One carton contains one packaged tray which contains: 1 vial with lyophilized powder for reconstitution, 1 pre-filled syringe with diluent, 1 20-gauge needle, 1 27-gauge needle, Sterile - For subcutaneous use only, Rx Only, Manufactured by: GP Pharm S.A. Barcelona, Spain (ESP) -08777, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0809-2023", "product_description": "HydrALAZINE HCl Injection, USP, 20 mg/mL, 1 mL Single Dose vials, For Intramuscular or Intravenous Use, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0111-2023", "product_description": "Prostaglandin (E1) Injection Solution, 25mcg/ml, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "108 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11252022@12, Exp 1/9/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Pearl River", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91576", "recalling_firm": "Urban Electric Power", "address_1": "401 N Middletown Rd Bldg 155", "address_2": "", "postal_code": "10965-1298", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0263-2023", "product_description": "Ohm Hand Sanitizer (alcohol (ethanol) 70 % v/v), packaged in a) 2 FL OZ (60 ML), b) 3 FL OZ (88 ML) bottles, c) 10 FL OZ (295 ML) bottles, d)12 FL OZ (355 ML) bottles, e)16 FL OZ (473 ML) bottles,  f) 64 FL OZ (1892 ML) bottles, g) 128 FL OZ (3785 ML) bottles", "product_quantity": "a) 239 bottles, b) 6,352 bottles, c)14,963 bottles, d) 8,117 bottles, e)22 bottles, f)856 bottles, g) 707 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20230117", "center_classification_date": "20230208", "termination_date": "20240226", "report_date": "20230215", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0989-2023", "product_description": "potassium phosphate 15 mmole added to 0.9% sodium Chloride 250 mL, IV Bag, RX Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6060-1", "product_quantity": "7469 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239332, Exp. 7/11/2023; 36-241113, Exp. 7/18/2023; 36-242467, 7/25/2023; 36-243530, 36-243659, Exp. 7/30/2023; 36-244888, 8/1/2023, 36-245657, 36-245658, Exp. 8/2/2023; 36-246835, Exp. 8/7/2023; 36-247595, Exp. 8/9/2023; 36-248736, Exp. 8/15/2023;  36-248984, 36-248985, Exp. 8/16/2023; 36-250054, 36-250055, 36-250056, 36-250057, 36-250058, Exp. 8/22/2023; 36-251046, 36-251047, 36-251048, 36-251049, Exp. 8/24/2023; 36-251975, Exp. 8/30/2023; 36-255877, 36-255878, 36-255879, Exp. 9/10/2023."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1074-2023", "product_description": "lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1", "product_quantity": "9,517 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-271076, Exp. 7/24/2023; 17-271132, 17-271165, Exp. 7/25/2023; 17-271230, 17-271250, Exp. 7/26/2023; 17-271508, Exp. 7/31/2023; 17-271595, 17-271604, Exp. 8/1/2023;  17-271658, Exp. 8/2/2023; 17-271764, Exp. 8/3/2023; 17-271826, Exp. 8/6/2023; 17-271972, Exp. 8/8/2023; 17-272052, 17-272057, Exp. 8/9/2023; 17-272139, Exp. 8/10/2023; 17-272258, Exp. 8/14/2023; 17-272470, Exp. 8/16/2023; 17-272690, Exp. 8/20/2023; 17-272822, Exp. 8/23/2023; 17-273054, 17-273065, Exp. 8/28/2023; 17-273423, Exp. 9/2/2023; 17-273771, Exp. 9/7/2023."}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0284-2023", "product_description": "D5 NS 2300ML, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320,", "product_quantity": "2", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 26, 2022"}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA062912"], "brand_name": ["VANCOMYCIN HYDROCHLORIDE"], "generic_name": ["VANCOMYCIN HYDROCHLORIDE"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-3515", "0409-6531", "0409-6533", "0409-4332"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["VANCOMYCIN HYDROCHLORIDE"], "rxcui": ["1807513", "1807516", "1807518", "2049890"], "spl_id": ["6b13ef5a-c456-4bcf-a9ec-ddc91bbd809a"], "spl_set_id": ["f2901045-904f-47bd-74a1-c561facd7f25"], "package_ndc": ["0409-6531-12", "0409-6531-02", "0409-6533-11", "0409-6533-01", "0409-6533-21", "0409-4332-11", "0409-4332-01", "0409-3515-11", "0409-3515-01"], "is_original_packager": [true], "unii": ["71WO621TJD"]}, "product_type": "Drugs", "event_id": "91346", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA nationwide and Puerto Rico", "recall_number": "D-0184-2023", "product_description": "Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial,  10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045.  NDC Vial 0409-3515-11; NDC Carton 0409-3515-01", "product_quantity": "89,700 vials", "reason_for_recall": "Presence of Particulate Matter: Glass particulate matter detected in injectable.", "recall_initiation_date": "20221222", "center_classification_date": "20230125", "termination_date": "20240807", "report_date": "20230201", "code_info": "Lot: 33045BA, EXP 1SEP2023", "more_code_info": ""}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0709-2023", "product_description": "oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA  18106, NDC 72185-6043-1.", "product_quantity": "5544 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-883938, Exp 05/02/2023; 37-884910, 37-884915, Exp 05/07/2023; 37-886041, Exp 05/10/2023; 37-887515, 37-887520, Exp 05/16/2023; 37-888318, Exp 05/21/2023; 37-888847, Exp 05/22/2023; 37-890535, Exp 05/29/2023; 37-890957, Exp 05/30/2023; 37-891566, 37-891568, Exp 06/01/2023; 37-892156, Exp 06/05/2023; 37-893165, 37-893166, Exp 06/08/2023; 37-893994, 37-893995, Exp 06/12/2023; 37-895771, 37-895773, 37-895775, Exp 06/19/2023; 37-896614, Exp 06/21/2023; 37-900377, Exp 07/06/2023"}, {"status": "Terminated", "city": "La Vergne", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93339", "recalling_firm": "The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories", "address_1": "341 Mason Rd", "address_2": "N/A", "postal_code": "37086-3606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0107-2024", "product_description": "Polyvinyl Alcohol 1.4% Lubricating Eye Drops, packaged in 0.5 FL OZ (15mL) bottles, Dist. by: RUGBY LABORATORIES, Livonia, MI 48152, NDC 0536-1325-94.", "product_quantity": "1,271,810 bottles", "reason_for_recall": "Non-Sterility: FDA found insanitary conditions and positive bacterial test results from environmental sampling  at the manufacturing facility.", "recall_initiation_date": "20231031", "center_classification_date": "20231117", "termination_date": "20250415", "report_date": "20231129", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0606-2023", "product_description": "Cefepime for Injection, USP 2 grams per vial, Rx only, Mfd. for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-009-20", "product_quantity": "107,320 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1070-2023", "product_description": "fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride, Total Volume = 100 mL, Total FentaNYL 200 mcg/100 mL,  100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-1", "product_quantity": "1,114 bags", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-274485, Exp. 9/19/2023; 17-270783, Exp. 7/19/2023; 17-270882, Exp. 7/20/2023; 17-271430, Exp. 7/30/2023; 17-271509, Exp. 7/31/2023; 17-272224, 17-272238, Exp. 8/13/2023; 17-272704, Exp. 8/21/2023; 17-273147, Exp. 8/29/2023."}, {"status": "Ongoing", "city": "Tesuque", "state": "NM", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92952", "recalling_firm": "Dr. Berne's Whole Health Products", "address_1": "174 Tesuque Village Rd Unit 458", "address_2": "N/A", "postal_code": "87574-2030", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and UK, Canada, Italy, India, Australia, Germany, Switzerland, Singapore, Netherlands, Ireland, South Korea, Belgium, Norway, Saudi- Arabia, Slovenia, Malta, Israel, Sweden, Latvia, Portugal, Hong Kong, Kuwait, Romania, South Africa, Thailand, Zambia, France, Finland, Mauritius, Barbados.", "recall_number": "D-0033-2024", "product_description": "Dr. Berne's MSM DROPS 15% Solution, 30 mL/1.014 OZ bottle, Distributed by: Dr. Berne's Whole Health Products, Tesuque, NM, 87574, hello@drsamberne.com, UPC 00854582001036", "product_quantity": "6060 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20230826", "center_classification_date": "20231004", "report_date": "20231011", "code_info": "Lots: 6486, Exp: 11/23; 6536, Exp: 01/24; 6549, Exp: 02/24; 6561, Exp: 03/24; 6623, Exp: 06/24; 6630, Exp: 06/24; 6646, Exp: 07/24; 6675, Exp: 09/24; 6686, Exp: 09/24; 6695, Exp: 10/24; 6738, Exp: 11/24; 6767, Exp: 01/25; 6787, Exp: 03/25; 6799, Exp: 04/25; 6832 Exp: 05/25; 6844, Exp: 05/25; 6857, Exp: 06/25; 6888, Exp: 07/25."}, {"status": "Ongoing", "city": "Piscataway", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA210692"], "brand_name": ["ATOVAQUONE"], "generic_name": ["ATOVAQUONE"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "product_ndc": ["31722-629"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOVAQUONE"], "rxcui": ["308429"], "spl_id": ["151b9723-5db4-ac2b-e063-6294a90af073"], "spl_set_id": ["2445304e-4b4e-4358-b098-31f3c49c52ef"], "package_ndc": ["31722-629-21"], "is_original_packager": [true], "nui": ["N0000175482", "N0000175485"], "pharm_class_epc": ["Antimalarial [EPC]", "Antiprotozoal [EPC]"], "unii": ["Y883P1Z2LT"]}, "product_type": "Drugs", "event_id": "91808", "recalling_firm": "Camber Pharmaceuticals Inc.", "address_1": "800 Centennial Ave Ste 1", "address_2": "N/A", "postal_code": "08854", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0567-2023", "product_description": "Atovaquone Oral Suspension USP, 750 mg/5 mL, Packaged in 210 mL bottle, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured by: Hetero Labs Limited, Jeedimetla, Hyderabad - 500 055, India, NDC# 31722-629-21.", "product_quantity": "1568 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Product: Objectionable organism, identified as Bacillus cereus, found in product during testing of repackaged product.", "recall_initiation_date": "20230313", "center_classification_date": "20230508", "report_date": "20230517", "code_info": "Lot# E220182, Exp. 12/31/2023"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0028-2024", "product_description": "HYDROmorphone in 0.9% sodium chloride, 10 mg/50 mL, (0.2 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2010-2", "product_quantity": "1,190 50 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275728, Exp. 10/9/2023; 17-275791, 17-275803, Exp. 10/10/2023; 17-276244, Exp. 10/20/2023."}, {"status": "Terminated", "city": "Xiamen", "state": "N/A", "country": "China", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "91410", "recalling_firm": "GFA Production Xiamen Co. Ltd.", "address_1": "Huli Industrial Park No. 20", "address_2": "Meixi Road; Tong'An", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide and Canada.", "recall_number": "D-0249-2023", "product_description": "Easy Care First Aid 10 Person 2009 ANSI, First Aid Kit, containing Easy Care first aid After Burn Cream 0.9 g packets, Product # 9999-2128", "product_quantity": "194460 packets", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: FDA Laboratory results found product to be contaminated with Bacillus lichenformis and Bacillus sonorensis.", "recall_initiation_date": "20221223", "center_classification_date": "20230127", "termination_date": "20250729", "report_date": "20230208", "code_info": "Lot #: W05L28, exp 12/28/2023; W06F10, exp 06/10/2024; W06H15, exp 08/15/2024."}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91921", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0484-2023", "product_description": "Simvastatin, USP, 10 mg Tablets, Rx Only, Packaged as a a) 30-count bottle, NDC 61919-0688-30 b) 90-count bottle, NDC61919-0688-90, Packaged and Distributed By: Direct Rx, Dawsonville, GA 30534", "product_quantity": "30 count: 6 bottles; 90 count: 106 bottles", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20230313", "center_classification_date": "20230324", "termination_date": "20240617", "report_date": "20230405", "code_info": "a) [30-count bottles] Lot, expiry: 05AU2206, exp 10/31/23;  b) [90-count bottles] Lot, expiry: 30MA2213, exp 6/30/23; 10DE2124, exp 3/31/23; 15MA2224, exp 5/32/23; 27JA2229, exp 3/31/23."}]